Advanced Virology

What Advanced Virology does

Advanced Virology Inc. is a privately held biotechnology company founded in 2022 in Athens, Ohio, that manufactures and supplies high-fidelity virus stocks and derivative products using plasmid-based reverse genetics systems. The company operates a BSL-2 certified R&D and production laboratory and offers a catalog of 166 products spanning wild-type, chimeric, reporter (eGFP, mCherry, nLuc), inactivated, purified, and molecular tagged virus stocks, plus viral genomic material and custom virus-like particles, across 11 virus families including alphaviruses, flaviviruses, coronaviruses, influenza, RSV, parainfluenza, metapneumovirus, norovirus, rotavirus, and measles virus. Its core technical differentiation is a plasmid-based reverse genetics production method that engineers viruses from genetic sequences rather than serial passaging, combined with comprehensive quality control including NGS with variant calling, titer assays, and sterility and endotoxin testing. The company was co-founded by Doug Butdorf and William Klimstra and draws on a team with over 80 years of combined virology and molecular biology expertise.

Advanced Virology serves four primary customer segments: pharmaceutical companies (high-throughput screening and antiviral drug discovery), biotechnology innovators (vaccine development and gene therapy vectors), diagnostic companies (assay development and validation), and academic and government research institutions (foundational virology research). It generates revenue through one-time catalog purchases of experiment-ready virus stocks at pay-as-you-go pricing with volume discounts of 10-30% and a 60% academic discount, supplemented by custom virus production services for orders up to 50L, grant support consulting, and regulatory consultation. Distribution is primarily direct via a Shopify-powered e-commerce site, with additional reach through the Scientist.com marketplace, MTEC and RRPV consortium memberships, Ohio Life Sciences, and conference presence such as ASV 2025.

Named customers disclosed in source materials include USAMRIID (recombinant virus production with regulatory compliance), Ambient Biosciences (reporter model system for an Alphavirus), and academic laboratories, indicating traction across government/defense, biotech, and academic buyers. No funding rounds, revenue figures, or external institutional investors are disclosed, and the company appears to operate as an independent, founder-led entity at the 1-10 employee scale.

Name

Advanced Virology

Legal name

Advanced Virology Inc.

Website

https://advancedvirology.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

Advanced Virology Inc. is a privately held biotechnology company that manufactures high-fidelity virus stocks and derivative products using plasmid-based reverse genetics systems for pharmaceutical, biotech, diagnostic, academic, and government research customers worldwide.

Ownership category

akta.pro rank

Product category

Virology Research Products and Reagents

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Gene Therapy CDMO (Viral Vector Manufacturing) (HLAGAGAB)

akta.pro secondary industries

Cell Banking & Viral Seed Services (MCB/WCB/VSB) (HLAGAGAD), mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC), Gene Therapy CMC/Process Development Platforms (capsid engineering, producer cell lines, plasmids, upstream/downstream) (HLAAACAN)

Keywords

• Virus stock production
• Reverse genetics systems
• Custom virus manufacturing
• Virology research reagents
• BSL-2 production services

Headquarters

HQ city

Athens

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Virus Stock Product Sales: Sale of experiment-ready virus stocks including wild-type, chimeric, reporter viruses, purified viruses, inactivated viruses, and viral genomic material. One-time product purchase model with volume-based pricing discounts (10% for 2 vials, 20% for 3 vials, 30% for 4+ vials).
2. Custom Virus Production Services: Made-to-order virus production services providing exact volume of virus stock or derivative product from small seed stocks to large-scale batches. Pricing equivalent to or lower than in-house production costs. Includes tailored purification and QC solutions.
3. Grant Support Services: Technical consultation and feasibility data to strengthen grant proposals and shape successful studies. Partners with academic labs and biotech companies from early-stage concept to funding application.
4. Regulatory Consultation: Expert guidance on regulatory compliance aspects of virus production and usage. Supports customers with documentation and compliance requirements.

Pricing tiers

Go-to-market motion4 records

Distribution channels4 records

Marketing channels5 records

Core offering

Advanced Virology manufactures and sells high-fidelity virus stocks and derivative products (wild-type, reporter, chimeric, inactivated, purified, molecular tagged viruses, and viral genomic material) using plasmid-based reverse genetics systems. The company operates a BSL-2 production laboratory, offers custom virus production services up to 50L per run, and provides comprehensive QC including NGS verification, serving pharmaceutical, biotech, diagnostic, academic, and government research customers globally.

Product overview

Advanced Virology is a specialized biotechnology company that manufactures high-fidelity virus stocks and derivative products using plasmid-based reverse genetics systems. The company operates a BSL-2 certified facility and offers a portfolio of virus products across multiple families including Alphaviruses (Chikungunya, Sindbis, Venezuelan/Eastern/Western Equine Encephalitis, Mayaro), Flaviviruses (Dengue, Yellow Fever, West Nile, Zika), Coronaviruses (SARS-CoV-2, 229E, HKU1, NL63, OC43), Influenza, RSV, Parainfluenza, Metapneumovirus, Norovirus, and Rotavirus. Product offerings include Wild-type Virus Stocks, Reporter Virus Stocks (eGFP, mCherry, nLuc), Chimeric Virus Stocks, Viral Genomic Material, Inactivated Virus Stocks, Purified Virus Stocks, and Molecular Tagged Virus Stocks. Services include Custom Virus Production (up to 50L scale), Grant Support Services, and comprehensive Quality Control Testing. The company also offers Experiment-Ready Virus Supply - pre-packaged volumes eliminating the need for in-house amplification. Products are available through their e-commerce platform with academic pricing (60% discount) and volume discounts.

Differentiator

Problem solved

Functional benefit

Products and services

• Wild-type Virus Stocks High-fidelity wild-type virus stocks produced using plasmid-based reverse genetics systems, available across 11+ virus families including alphaviruses (Chikungunya, Sindbis, VEEV, EEEV, WEEV, Mayaro), flaviviruses (Dengue, Yellow Fever, Zika, West Nile), coronaviruses (SARS-CoV-2, OC43, NL63, 229E, HKU1), influenza, RSV, parainfluenza, metapneumovirus, norovirus, rotavirus, and measles virus. Designed for virology researchers in pharma, biotech, government, and academic labs.
• Reporter Virus Stocks Virus stocks engineered to express reporter proteins (eGFP, mCherry, nLuc) using Thosea asigna virus 2A-like protease insertion, enabling real-time monitoring of viral infection and replication for high-throughput antiviral screening and mechanistic studies. Targeted at pharmaceutical R&D and biotech organizations running drug discovery screens.
• Chimeric Virus Stocks Genetically engineered chimeric viruses combining genetic elements from different viral strains, such as Sindbis/Chikungunya and Sindbis/Equine Encephalitis chimeras, for research applications requiring specific viral gene combinations. Used by researchers studying viral pathogenesis and gene function.
• Viral Genomic Material Purified viral genomic material including synthetic RNA (in vitro transcribed) and genomic RNA purified from virus stocks, available for norovirus strains (GI and GII genogroups including GII.4, GII.17, GII.6, GII.7, GII.8) and other viruses. Designed for diagnostic assay developers and academic researchers needing quantified genetic material.
• Inactivated Virus Stocks Virus stocks that have been inactivated for safe handling in diagnostic assay development, validation, and cross-reactivity testing panels where live virus is not required. Targeted at diagnostic assay developers and academic labs needing safe positive controls.
• Purified Virus Stocks Virus stocks with enhanced purity achieved through purification processes, verified by silver stain or PAGE gel purity testing, suitable for applications requiring higher purity standards such as clinical research and vaccine development.
• Molecular Tagged Virus Stocks Virus stocks engineered with molecular tags for specific research applications requiring tagged viral genomes, enabling tracking and identification in experimental systems.
• Custom Virus Production Services Made-to-order virus production using plasmid-based reverse genetics systems, enabling de novo production of new virus strains including difficult-to-grow strains, from small seed stocks to large-scale batches up to 50L per production run. Includes tailored purification and QC solutions. Customers engage sales directly via custom order inquiry. Customers include biotech startups (Ambient Biosciences), government/defense research (USAMRIID), and academic labs.
• Grant Support Services Technical consultation and support for grant applications and research project planning, providing virus capabilities information, feasibility data, and technical insights to strengthen proposals. Partners with academic labs and biotech companies from early-stage concept to funding application.
• Quality Control Testing Services Comprehensive QC testing per production run including virus titer (plaque assay/TCID50/IFA), genome copy number (qPCR/ddPCR), Mycoplasma testing, next-generation sequencing with variant calling, sterility testing, endotoxin testing, and purity testing (silver stain/PAGE gel) for purified products.
• Bundibugyo Ebolavirus VLPs Custom-order Bundibugyo Ebolavirus virus-like particles (VLPs), non-replicating particles encapsidating minigenomes expressing GFP or nano Luciferase, designed for assay development, immunology research, vaccine research, diagnostics, and countermeasure evaluation in BSL-2 laboratories.

Quantifiable outcome

• 3-5 months of research time saved
• +2 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered core.

• Scientist.comcoreChannel Partner/ Reseller/ Distributor · 23 February 2026Partnered supplier on Scientist.com marketplace, providing research organizations convenient channel to access virology products and services. Announced live on platform February 2026.
• Medical Technology Enterprise Consortium (MTEC)coreOthersMember of MTEC, a consortium focused on advancing medical technology research and development. MTEC membership provides access to defense health research opportunities and collaborative partnerships.
• Rapid Response Partnership (RRPV)coreOthersMember of RRPV, a partnership focused on rapid response capabilities for public health emergencies and research needs.
• Ohio Life SciencescoreOthersMember of Ohio Life Sciences, the state's industry association for life sciences companies, providing networking, advocacy, and visibility within the regional ecosystem.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Aldevron (Danaher): Contract manufacturer of plasmids, mRNA, and viral vectors (AAV) for gene therapy and vaccine developers. Comparable CDMO-style viral manufacturing services but focused on clinical/commercial-stage biopharma rather than research-grade stocks.
• VectorBuilder: Custom viral vector (AAV, lentivirus, adenovirus) design and manufacturing provider with a global e-commerce-style platform. Comparable in offering online-orderable custom virus production at scale, but broader across gene therapy vectors.
• Charles River Laboratories: Large CRO/CDMO offering viral clearance, vaccine development, and viral manufacturing services. Broad incumbent whose virology services overlap with Advanced Virology's BSL-2 production for vaccine and antiviral programs.
• ATCC: Global biological resource center supplying authenticated cell lines, viruses, and microbial materials to research institutions and industry. A broad incumbent in standardized biological materials, overlapping on virus stocks but spanning far more categories.
• Takara Bio: Life science tools and CDMO provider offering viral vector production services (lentivirus, AAV, adenovirus) and viral reagents. Comparable as both a viral CDMO and a research reagent supplier, with significantly greater scale and geographic reach.

Direct peers

• Sino Biological: Global supplier of recombinant viral proteins, antigens, and virus-related reagents for research and diagnostic development. Comparable breadth of virology catalog and similar buyer base across pharma, biotech, and academic labs.
• Microbiologics: Producer of biological reference materials including viral and bacterial controls for diagnostic, academic, and pharmaceutical research. Comparable e-commerce-driven model supplying standardized biological products with QC documentation.
• The Native Antigen Company (part of LGC Clinical Diagnostics): Manufacturer of viral antigens and infectious disease reagents used by diagnostic manufacturers and academic researchers. Comparable as a specialist in virology-derived research reagents with quality documentation for regulated buyers.
• ZeptoMetrix (Antylia Scientific): Supplier of inactivated viruses, viral antigens, and NATtrol controls for diagnostic and research use. Directly comparable as a catalog-based supplier of virus-derived research materials serving diagnostics and pharma customers.
• Virapur: Specialty contract manufacturer of high-titer virus stocks and viral vectors for research, diagnostic, and biotherapeutic customers. Direct peer in virus production services using similar BSL-2 capabilities and serving overlapping pharma/biotech/academic segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks4 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/advancedvirology

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Advanced Virology